drugset / Trial / NCT00483964
A Safety and Efficacy Study of Bacopa Monnieri and Nardostachys Jatamansi to Treat Schizophrenia
Phase 2
Completed
200 enrolled
Q.Mundewadi Ayurvedic Research & Charitable Trust
Stanley Medical Research Institute · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether a herbal combination of water based extracts of Bacopa monnieri(BM) and Nardostachys jatamansi(NJ) is effective in the treatment of Schizophrenia. The working hypothesis for this study is that a herbal combination of BM and NJ will be as effective as modern anti-psychotic drugs, in the treatment of Schizophrenia, and will be safe for long term use.
Timeline
- Start
- 2005-09
- Primary completion
- —
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bacopa monnieri | Unknown | 400 mg | — |
| Subject | Nardostachys jatamansi | Unknown | 200 mg | — |
| Comparator | Olanzapine | Small molecule | 10 mg | — |